Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Werewolf Therapeutics
Biotech
BioMarin hires ex-Roche leader Hubbard as CCO—Chutes & Ladders
BioMarin names Hubbard as new CCO. Marett is retiring from BioNTech. GSK plucks Flagship partner as new SVP of research technologies.
Max Bayer
,
Gabrielle Masson
Mar 8, 2024 9:30am
Jazz, Werewolf to howl at the moon in $1.26M biobucks deal
Apr 7, 2022 9:35am
Synthekine snags $108M to drive two candidates into the clinic
Jun 10, 2021 8:00am
Werewolf Therapeutics howls onto the Nasdaq with $120M IPO
Apr 30, 2021 10:16am
Werewolf Therapeutics looks to make a killing on the Nasdaq
Apr 9, 2021 8:20am
Werewolf banks $72M to shepherd shape-shifting cancer meds
Jan 7, 2021 7:00am
